Nanjing Cavendish Bio-Engineering Tech. Co., LTD.
Records under this name other than the patents Nanjing Cavendish Bio-Engineering Tech. Co., LTD. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 3 of 3 · Back to Nanjing Cavendish Bio-Engineering Tech. Co., LTD.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,465,970 | Method for Synthesis of Roxadustat and Intermediate Compounds Thereof Lapsed on the fee record Ended Oct 11, 2026 · High confidence | Lapsed on the fee record | Ended Oct 11, 2026 | High confidence |
| US 8,586,592 | Pharmaceutical formulations comprising voriconazole and processes for preparation thereof Lapsed on the fee record Ended Nov 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 19, 2025 | From the USPTO record |
| US 8,324,373 | Highly stereoselective process for preparing gemcitabine and intermediates thereof Lapsed on the fee record Ended Dec 4, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 4, 2020 | From the USPTO record |